Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
released

Certificate of analysis

Dihexa

Lot CP-DIHEXA-2605B · 10 mg

98.55 %

HPLC purity

Spec ≥ 98.0 %

91.5 %

Net peptide content

By amino acid analysis

< 0.75

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Janoshik Analytical
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
May 14, 2026
Release tested
May 23, 2026 (4 months ago)
Retest date
May 13, 2028
CAS number
1401708-83-5
Molecular formula
C29H46N4O5
Theoretical mass
530.70 Da
Observed mass (LC-MS)
530.41 Da (Δ 0.29 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 98.0 %98.55 %Pass
LC-MS (ESI+)Identity — observed mass530.70 ± 1.0 Da530.41 DaPass
Amino acid analysisNet peptide content≥ 80.0 %91.5 %Pass
Karl FischerWater content≤ 8.0 %3.36 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.13 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.75 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Handling for this lot

Appearance
White to off-white powder
Storage
-20 °C, desiccated
Reconstitution
Prepare a concentrated DMSO stock first. Adding water directly to the vial will not dissolve this compound.

Other lots of Dihexa

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.